ContractSubscription Agreement • February 8th, 2019 • InventaBioTech Inc. • Surgical & medical instruments & apparatus • New York
Subscription Agreement Number: January , 2019 Issued to: in connection with the Offering by InventaBioTech Inc. of A Minimum of $100,000.000 and a Maximum Principal Amount of $1,000,000 of Convertible Promissory Notes payable on bearing interest at the annual rate of 12% and convertible into equity securities of the Company as set forth in the Notes Placement Agent DIVINE CAPITAL MARKETS LLC 39 BROADWAY 36TH FLOOR NEW YORK, NEW YORK 10006 CONFIDENTIAL USE ONLY - MAY NOT BE REPRODUCED NOTICES NONE OF THE NOTES OR THE SECURITIES INTO WHICH THE NOTES WILL BE CONVERTIBLE (COLLECTIVELY, THE "SECURITIES") HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS. THESE SECURITIES ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THESE LAWS. THE NOTES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION (THE "COMMISSION") OR ANY STATE SECURITIES REGULATORY AUTHORITY NOR HAS THE
Inventa 80Tcch Employment Agreement Title: Interim CEO at InventaBioTech. Employed Full Time and based in NY (no requirement to relocate to San Antonio). Note: The Interim CEO will to disclose his current Divine activities to allow him to carve out...InventaBioTech Inc. • February 8th, 2019 • Surgical & medical instruments & apparatus
